Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Chaplin

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|March 27, 2020
A Modified Vaccine against Smallpox. ReplyPhillip R Pittman, Heinz Weidenthaler, Paul Chaplin
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptidesReinhold Schirmbeck, Nicolas Fissolo, Paul Chaplin, et al.
Vaccine|September 15, 2005
Genetic stability of recombinant MVA-BNAlexandra Timm, Christiane Enzinger, Eva Felder, et al.
The Journal of the American Academy of Psychiatry and the Law|March 19, 2013
Commentary: toward an improved understanding of administrative segregationRobert H Berger, M Paul Chaplin, Robert L Trestman
Parasite Immunology|March 5, 2002
Fasciola hepatica cathepsin L suppresses sheep lymphocyte proliferation in vitro and modulates surface CD4 expression on human and ovine T cellsRhoda K Prowse, Paul Chaplin, H Clem Robinson, et al.
Vaccine|March 11, 2014
Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individualsSharon E Frey, Patricia L Winokur, Heather Hill, et al.
Frontiers in Immunology|August 30, 2013
Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated ImmunityHenning Lauterbach, Juliane Pätzold, Ronny Kassub, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2003
Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 biasTonia Woodberry, Joy Gardner, Suzanne L Elliott, et al.
Vaccine|March 31, 2018
A single vaccination with non-replicating MVA at birth induces both immediate and long-term protective immune responsesCédric Cheminay, Jana Körner, Constanze Bernig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old miceMarco Franchini, Hanspeter Hefti, Sabine Vollstedt, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|March 27, 2020
A Modified Vaccine against Smallpox. ReplyPhillip R Pittman, Heinz Weidenthaler, Paul Chaplin
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2003
Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptidesReinhold Schirmbeck, Nicolas Fissolo, Paul Chaplin, et al.
Vaccine|September 15, 2005
Genetic stability of recombinant MVA-BNAlexandra Timm, Christiane Enzinger, Eva Felder, et al.
The Journal of the American Academy of Psychiatry and the Law|March 19, 2013
Commentary: toward an improved understanding of administrative segregationRobert H Berger, M Paul Chaplin, Robert L Trestman
Parasite Immunology|March 5, 2002
Fasciola hepatica cathepsin L suppresses sheep lymphocyte proliferation in vitro and modulates surface CD4 expression on human and ovine T cellsRhoda K Prowse, Paul Chaplin, H Clem Robinson, et al.
Vaccine|March 11, 2014
Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individualsSharon E Frey, Patricia L Winokur, Heather Hill, et al.
Frontiers in Immunology|August 30, 2013
Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated ImmunityHenning Lauterbach, Juliane Pätzold, Ronny Kassub, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2003
Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 biasTonia Woodberry, Joy Gardner, Suzanne L Elliott, et al.
Vaccine|March 31, 2018
A single vaccination with non-replicating MVA at birth induces both immediate and long-term protective immune responsesCédric Cheminay, Jana Körner, Constanze Bernig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old miceMarco Franchini, Hanspeter Hefti, Sabine Vollstedt, et al.
Pageof 6